Aaronson Rappaport Partner, Elliott Zucker, will participate in a panel “Let’s Talk Talc” at the 2019 CLM Annual Conference in Orlando, Florida, along with noted claims analysts from Swiss Re and Rimkus Consulting Group, Inc. The panel will explore recent developments in litigation surrounding talcum powder and scenarios faced by property owners and managers, security contractors, and tenants in analyzing these product liability claims.

Aaronson Rappaport Partner, Peter J. Fazio, testified on February 8, 2019, before the Federal Civil Rules Committee in Washington, D.C.  in reference to the proposed amendment to Federal Rule of Civil Procedure 30(b)(6). Currently, and in part, the proposed amendment would require the parties to confer in advance regarding the identity of the person who will testify.  Many have come forward opposing the proposed amendment and argued that it would create a new discovery obligation that has never existed and is not needed.  The unnecessary obligation would create a new basis for disputes accompanied by motion practice. The law is

New York’s highest Court affirms the trial Court’s decision that plaintiff’s proof failed to establish a legally sufficient connection between the defendant’s products and the decedent’s alleged exposure to asbestos.  In the Matter of New York City Asbestos Litigation (Juni)

Aaronson Rappaport Partner, Philip Lerner participated in a discussion on litigating medical malpractice trials with a New York State Trial Lawyers Association panel moderated by Honorable Marsha Steinhardt of the Kings County Supreme Court. The panel discussion focused on jury selection and the creation of opening statements and summations.  

Barbara Ryan was invited to act as panel moderator regarding OPMC-related issues at the annual NYS Bar, Health Law Division meeting on Jan. 16, 2019.